Apple is gearing up for its next big launch aka iPhone 14 series later this year. If the latest reports are to be believed, the iPhone 14 series will use the Apple A16 Bionic chipset based on the same 5nm node that was used in the A15 Bionic chipset.
This comes from popular Apple Analyst Ming-Chi Kuo according to whom, it has come to her notice that the iPhone 14 series will use the same fabrication method as that of the iPhone 13 series. It will be manufactured by China’s TSMC and on the 5nm node that Apple has been using in the last two iterations, this will make it three consecutive years.
The report further adds that the Apple A16 Bionic chipset based on the typical nomenclature that Apple uses to name its chipsets is reserved for the Pro variants only. This counts for both iPhone 14 Pro and iPhone 14 Pro Max while the non-pro variants will retain the A15 Bionic chipset only.
Taking about the performance and efficiency gains, the A15 chipset produced 10% higher performance than the A14 chipset. However, Kuo believes that the performance gains using the same chipset will be minor. Apart from that, Apple has been leading in terms of performance and throughput its chipsets have been provided for generations now. Using the same chipset with different marketing names wouldn’t introduce the better performance.
The next-gen chipset made on smaller fabrication methods won’t be rolled out this next year. This could be possibly because there’s been a heavy chip shortage for months now. If iPhone’s chipsets weren’t enough, the next-gen M2 chipsets won’t get a higher performance gain as well since the Cupertino-based giant has likely decided to use the same marketing technique it will use with iPhone’s chipsets.
